WQ
Wealth Quarterback’s CRISPR Therapeutics CRSP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-7,909
| Closed | -$359K | – | 120 |
|
2023
Q3 | $359K | Sell |
7,909
-166
| -2% | -$7.54K | 0.31% | 76 |
|
2023
Q2 | $453K | Sell |
8,075
-164
| -2% | -$9.21K | 0.31% | 72 |
|
2023
Q1 | $373K | Buy |
8,239
+34
| +0.4% | +$1.54K | 0.32% | 71 |
|
2022
Q4 | $334K | Sell |
8,205
-13
| -0.2% | -$528 | 0.28% | 78 |
|
2022
Q3 | $537K | Sell |
8,218
-217
| -3% | -$14.2K | 0.57% | 45 |
|
2022
Q2 | $513K | Buy |
+8,435
| New | +$513K | 0.4% | 53 |
|
2021
Q3 | $638K | Sell |
5,943
-205
| -3% | -$22K | 0.42% | 53 |
|
2021
Q2 | $996K | Buy |
+6,148
| New | +$996K | 0.61% | 33 |
|
2020
Q2 | – | Sell |
-75
| Closed | -$3.18K | – | 244 |
|
2020
Q1 | $3.18K | Hold |
75
| – | – | ﹤0.01% | 685 |
|
2019
Q4 | $4.57K | Buy |
+75
| New | +$4.57K | ﹤0.01% | 644 |
|